期刊文献+

生理药动学模型在家禽中的应用研究进展

Research Advances in Application of Physiologically Based Pharmacokinetics Models in Poultry
下载PDF
导出
摘要 生理药动学模型是一种基于物质平衡原理而建立的整体模型,能够预测化学异物在动物体内的吸收、分布、代谢和排泄规律。在兽医领域,生理药动学模型主要用于研究兽药的药动学特征、预测兽药的组织分布及残留休药期。目前,有关生理药动学模型的研究多集中在猪、牛、山羊、绵羊及狗,家禽的相关研究较少。家禽的解剖学结构与哺乳动物相比,差异巨大,且禽蛋的成分及形成过程均极其复杂,因此较难利用生理药动学模型预测家禽可食性组织及禽蛋中的兽药残留。通过对建模中所需的家禽的生理学及解剖学参数进行归纳总结,并对已有的家禽体内的生理药动学模型进行综述,同时分析了生理药动学模型在家禽体内应用的局限性。 Physiologically based pharmacokinetics(PBPK)model is a mathematical modeling technique for predicting the absorption,distribution,metabolism and excretion of chemical substances in animal species based on material balance principle. In veterinary medicine, the PBPK model has been used to study pharmacokinetics,tissue distribution and predict residue withdrawal time. At present,the researches of PBPK models are concentrated in pig,cattle,goat,sheep and dog,while there are few ones in poultry. The anatomical structures of poultry are very different from those of mammals. In addition, the composition of egg is very complex and the formation of egg is extremely complex. Therefore,it is difficult to predict drug residues in edible tissues and eggs based on PBPK model. In this paper,the physiological and anatomical parameters needed in poultry PBPK model were firstly summarized,then the literatures regarding the applicassion of PBPK model in poultry species were reviewed,and the limitations of PBPK model were finally analyzed.
出处 《中国家禽》 北大核心 2015年第9期42-45,共4页 China Poultry
基金 国家自然科学基金项目(31402253) 河南科技大学SRTP项目(2014267)
关键词 生理药动学模型 家禽 残留 预测 physiologically based pharmacokinetics model poultry residue prediction
  • 相关文献

参考文献19

  • 1白景英,杨帆,李亚男,王丹,孙灵灵,刘传发.基于生理模型和蒙特卡洛模拟预测多次灌胃后氟苯尼考在肉鸡体内的残留休药期[J].中国家禽,2015,37(2):15-20. 被引量:3
  • 2李亚男,孟小宾,王丹,孙灵灵,白景英,杨帆.基于生理药动学模型预测口服给药后氟苯尼考在肉鸡体内的残留[J].中国家禽,2014,36(14):17-21. 被引量:6
  • 3Buur J L, Baynes R E, Riviere J E. Estimating meat with- drawal times in pigs exposed to melamine contaminated feed us- ing a physiologically based pharmacokinetic model [J]. Regul Toxicol Pharmacol, 2008,51 (3) : 324-331. 被引量:1
  • 4Leavens T L, Tell L A, Kissell L W, et al. Development of a physiologically based pharmacokinetic model for flunixin in cat- tle(Bos taurus)[Jl. Food Addit Contain Part A Chem Anal Con- trol Expo Risk Assess,2014,31 (9) : 1506-1521. 被引量:1
  • 5Craigmill A L. A physiologically based pharmacokinetic mod- el for oxytetraeycline residues in sheep [J]. J Vet Pharmacol Ther, 2003,26( 1 ) : 55-63. 被引量:1
  • 6Leavens T L, Tell L A, Clothier K A, et al. Development of a physiologically based pharmacokinetic model to predict tulath- romyein distribution in goats[J]. J Vet Pharmacol Ther, 2012, 35 (2):121-131. 被引量:1
  • 7Gustafson D L, Rastatter J C, Colombo T, et al. Doxorubicin pharmacokinetics: Macromolecule binding, metabolism, and excre- tion in the context of a physiologic model[J]. J Pharm Sei,2002, 91 (6) : 1488-1501. 被引量:1
  • 8Brown R P, Delp M D, Lindstedt S L, et al. Physiological parameler values for physiologically based pharmaeokinetie mod- els[J]. Toxicol Ind Health, 1997,13(4) :407-484. 被引量:1
  • 9Upton R N. Organ weights and blood flows of sheep and pig for physiological pharmacokinetic modelling[J]. J Pharma- col Toxieol Methods,2008,58(3) : 198-205. 被引量:1
  • 10Cortright K A,Wetzlich S E,Craigmill A L. A PBPK mod- el for midazolam in four avian species [J]. J Vet Pharrnaeol Ther, 2009,32(6) : 552-565. 被引量:1

二级参考文献48

  • 1Garg A,Balthasar J P. Physiolugically-based pharmacokinetic (PBPK) model to predict lgG tissue kinetics in wild-type and FcRn-knockout mice [J]. J Pharnlacokinet Pharmacodyn,2007,34 (5) :687-709. 被引量:1
  • 2Buur J,Baynes R,Smith G,et al. Use of probabilistic modeling within a physiologically based pharmacokinetic model to predict sulfamethazine residue withdrawal times in edible tissues in swine [J]. Antimicrob Agents Cbemother,2006,50(7):2344-2351. 被引量:1
  • 3Craigmill A L. A physiologically based pharmacokinetic model for oxytetracycline residues m sheep [J]. J Vet Pharmacol Ther, 2003,26(1 ) :55-63. 被引量:1
  • 4Jones H M,Gardner 1 B,Watson K J. Modelling and PBPK simulation in drug discovery[J]. AAPS J ,2009,11 ( 1 ) : 155-166. 被引量:1
  • 5Peters S A,Ungell A L,Dolgos H. Physiologically based pharmacokinetic (PBPK) modeling and simulation:applications in lead optimization [J]. Curr Opin Drug Discov Devel,2009,12 (4) :509-518. 被引量:1
  • 6Sweeney L M,Kirman C R,Gannon S A,et al. Development of a physiologically based pharmacokinetic (PBPK) model for methyl iodide in rats,rabbits,and humans [J]. Inhal Toxicol,2009.21(6): 552-582. 被引量:1
  • 7Cortright K A,Wctzlich S E,Craigqnill A L. A PBPK model for midazolam in four avian species[J].J Vet Pharmacol Ther, 2009,32 (6) : 552-565. 被引量:1
  • 8Corley R A,Gies R A,Wu H,etal. Development of a physiologically based pharmacokinetic model for propylene glycol monomethyl ether and its acetate in rats and humans [J]. Toxicol Lett,2005,156(1) : 193-213. 被引量:1
  • 9Campbell A. Development of PBPK model of molmate and lnolinate sulfoxide in rats and humans [J]. Regul Toxicol Pharmacol. 2009,53(3) : 195-204. 被引量:1
  • 10Andrew M A,Hebert M F,Vicini P. Physiologically based pharmacokinetic model of midazolam disposition during pregnancy [J]. Conf Proc IEEE Eng Med Biol Soc,2008,5454-5457. 被引量:1

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部